图示 |
商品编号 |
商品名称 |
商品简介 |
操作 |
 |
S0058 |
Sorafenib tosylate |
Sorafenib Tosylate(对甲苯磺酸索拉非尼) is the tosylate salt of sorafenib, a synthetic compound targeting growth signaling and angiogenesis.
|
查看 |
 |
S0109 |
Trametinib |
Trametinib(曲美替尼) is an orally bioavailable inhibitor of mitogen-activated protein kinase kinase (MEK MAPK/ERK kinase) with potential antineoplastic activity.
|
查看 |
 |
S0110 |
Sorafenib |
Sorafenib(索拉非尼) is a synthetic compound targeting growth signaling and angiogenesis.
|
查看 |
 |
S0131 |
SCH-772984 |
SCH772984 is a novel, specific inhibitor of ERK1/2 with IC50 values of 4 nM and 1 nM in cell-free assay, respectively, And show robust efficacy in RAS- or BRAF-mutant cancer cells.
|
查看 |
 |
S0186 |
SB203580 |
SB203580 is a p38 MAPK inhibitor.
|
查看 |
 |
S0313 |
Vemurafenib |
Vemurafenib(维罗菲尼) is an orally bioavailable, ATP-competitive, small-molecule inhibitor of BRAF(V600E) kinase with potential antineoplastic activity.
|
查看 |